A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Journal article
Sampson O. et al, (2022), J Immunol Methods, 504
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nature communications, 13
Infection of liver hepatocytes with SARS-CoV-2.
Journal article
Barnes E., (2022), Nature metabolism, 4, 301 - 302
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Journal article
Townsend A. et al, (2021), Nature Communications, 12
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
Journal article
Wang T. et al, (2021), BMC Infectious Diseases, 21
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Journal article
Ogbe A. et al, (2021), Nature Communications, 12
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
Journal article
Wang T. et al, (2021), Hepatology Communications, 5, 1586 - 1604
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy
Journal article
Smith DA. et al, (2021), Journal of Viral Hepatitis, 28, 1256 - 1264
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
Journal article
Mokaya J. et al, (2021), Journal of Viral Hepatitis, 28, 1110 - 1120
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Journal article
Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
Therapeutic vaccination for treatment of chronic hepatitis B.
Journal article
Cargill T. and Barnes E., (2021), Clinical and experimental immunology, 205, 106 - 118
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.
Journal article
Webb GJ. et al, (2021), Journal of hepatology, 75, 226 - 228
High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study
Journal article
Flower B. et al, (2021), Open Forum Infectious Diseases, 8
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
SARS-CoV-2 infection in patients with autoimmune hepatitis.
Journal article
Marjot T. et al, (2021), Journal of hepatology, 74, 1335 - 1343
The rs738409 G Allele in PNPLA3 Is Associated With a Reduced Risk of COVID-19 Mortality and Hospitalization.
Journal article
Innes H. et al, (2021), Gastroenterology, 160, 2599 - 2601.e2
Antibody evasion by the P.1 strain of SARS-CoV-2
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9
COVID-19 and liver disease: mechanistic and clinical perspectives.
Journal article
Marjot T. et al, (2021), Nature reviews. Gastroenterology & hepatology, 18, 348 - 364